The knockdown of PIM3 with siRNA or treatment with the pan-PIM inhibitors AZD1208 or PIM447 resulted in decreased hepatoblastoma cell viability, motility, and attachment-independent growth [100,102]. Here, PIM1 is linked to hepatoblastoma.